Edgen Stock·Sep 20 2025, 18:33戻る
戻る
Amgen Shares Advance Following EMA Recommendation for Uplizna
Edgen Stock·Sep 20 2025, 18:33
[1] EMA Backs Amgen Drug For Rare Autoimmune Disorder (https://finance.yahoo.com/news/ema-backs-amge ...)[2] Amgen's Uplizna: A Regulatory and Commercial Breakthrough in IgG4-Related Disease (https://vertexaisearch.cloud.google.com/groun ...)[3] Why Amgen (AMGN) Stock Is Trading Up Today - StockStory (https://vertexaisearch.cloud.google.com/groun ...)